Table 1 Sociodemographic and medical characteristics at baseline
Total sample | Intervention group | Control group | |
|---|---|---|---|
N (%) | N (%) | N (%) | |
Gender | |||
Male | 141 (58.8) | 64 (52.9) | 77 (64.7) |
Female | 96 (40.0) | 56 (46.3) | 40 (33.6) |
NA | 3 (1.2) | 1 (0.8) | 2 (1.7) |
Marital status | |||
Single | 26 (10.8) | 14 (11.6) | 12 (10.1) |
In a relationship | 26 (10.8) | 15 (12.4) | 11 (9.2) |
Married | 141 (58.8) | 71 (58.7) | 70 (58.8) |
Separated/divorced | 27 (11.2) | 17 (14.0) | 10 (8.4) |
Widowed | 15 (6.2) | 4 (3.3) | 11 (9.2) |
NA | 5 (2.1) | 0 (0.0) | 5 (4.2) |
Educational level | |||
No degree | 6 (2.5) | 5 (4.1) | 1 (0.8) |
Lower secondary education | 69 (28.7) | 36 (29.8) | 33 (27.7) |
Higher secondary education | 70 (29.2) | 38 (31.4) | 32 (26.9) |
Higher education entrance qualification | 52 (21.7) | 27 (22.3) | 25 (21.0) |
University education | 34 (14.2) | 12 (9.9) | 22 (18.5) |
Other | 3 (1.2) | 2 (1.7) | 1 (0.8) |
NA | 6 (2.5) | 1 (0.8) | 5 (4.2) |
Occupational status | |||
Unemployed | 19 (7.9) | 7 (5.8) | 12 (10.1) |
Sick leave | 9 (3.8) | 6 (5.0) | 3 (2.5) |
Part-time employed | 22 (9.2) | 10 (8.3) | 12 (10.1) |
Full-time employed | 53 (22.1) | 31 (25.6) | 22 (18.5) |
Retired | 120 (50.0) | 61 (50.4) | 59 (49.6) |
NA | 17 (7.1) | 6 (5.0) | 11 (9.2) |
Place of residence (population size) | |||
Large city (>100,000 residents) | 190 (79.2) | 92 (76.0) | 98 (82.4) |
Medium-sized city (>20,000 residents) | 29 (12.1) | 20 (16.5) | 9 (7.6) |
Small town (>5000 residents) | 12 (5.0) | 7 (5.8) | 5 (4.2) |
Rural area (<5000 residents) | 4 (1.7) | 2 (1.7) | 2 (1.7) |
NA | 5 (2.1) | 0 (0.0) | 5 (4.2) |
BMI (kg/m2) | 28.55 (5.87) | 29.26 (6.67) | 27.82 (4.84) |
Smoking | |||
Currently | 60 (25.0) | 34 (28.1) | 26 (21.8) |
In the past | 76 (31.7) | 37 (30.6) | 39 (32.8) |
Coronary artery bypass graft (CABG) | 22 (9.2) | 17 (14.0) | 5 (4.2) |
Percutaneous coronary intervention (PCI) | 100 (41.7) | 50 (41.3) | 50 (42.0) |
Peripheral artery disease (PAD) | 88 (36.7) | 43 (35.5) | 45 (37.8) |
Peripheral bypass | 10 (4.2) | 6 (5.0) | 4 (3.4) |
Percutaneous transluminal angioplasty | 50 (20.8) | 27 (22.3) | 23 (19.3) |
Chronic vein insufficiency | 14 (5.8) | 8 (6.6) | 6 (5.0) |
Amputation | 2 (0.8) | 0 (0.0) | 2 (1.7) |
Deep vein thrombosis | 13 (5.4) | 9 (7.4) | 4 (3.4) |
Pulmonary embolism | 9 (3.8) | 4 (3.3) | 5 (4.2) |
Acute coronary syndrome | 35 (14.6) | 21 (17.4) | 14 (11.8) |
Angina pectoris | 25 (10.4) | 15 (12.4) | 10 (8.4) |
Congestive heart failure | 63 (26.2) | 29 (24.0) | 34 (28.6) |
Valvular disease | 62 (25.8) | 26 (21.5) | 36 (30.3) |
Intervention | 7 (2.9) | 1 (0.8) | 6 (5.0) |
Stroke | 14 (5.8) | 6 (5.0) | 8 (6.7) |
Transient ischemic attack | 1 (0.4) | 1 (0.8) | 0 (0.0) |
Type 2 diabetes | 41 (17.1) | 26 (21.5) | 15 (12.6) |
Diabetes mellitus type 1 or 2 | 41 (17.1) | 23 (19.0) | 18 (15.1) |
Arterial hypertension | 193 (80.4) | 95 (78.5) | 98 (82.4) |
Pulmonary hypertension | 4 (1.7) | 2 (1.7) | 2 (1.7) |
Hyperlipidemia | 191 (79.6) | 92 (76.0) | 99 (83.2) |
Hyperuricemia | 8 (3.3) | 3 (2.5) | 5 (4.2) |
Medication | |||
Blood pressure | 179 (74.6) | 96 (79.3) | 83 (69.7) |
Cholesterol | 170 (70.8) | 94 (77.7) | 76 (63.9) |
Aspirin (acetylsalicylic acid) | 123 (51.2) | 65 (53.7) | 58 (48.7) |
Mental illness | 39 (16.2) | 21 (17.4) | 18 (15.1) |
Dropout | 41 (17.1) | 17 (14.0) | 24 (20.2) |
Total | N = 240 | N = 121 | N = 119 |
